GRI
GRI Bio Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.65M
P/E Ratio
0.05
EPS
$38.89
Beta
-0.77
52W High
$80.36
52W Low
$1.97
50-Day MA
$2.35
200-Day MA
$23.94
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About GRI Bio Inc.
GRI Bio Inc. is an innovative biotechnology firm dedicated to transforming patient care through its proprietary microbiome technology platform. The company focuses on developing groundbreaking therapies aimed at addressing unmet medical needs in immunology and oncology, prioritizing the treatment of disease causes over mere symptom management. With a comprehensive pipeline of product candidates and strategic research collaborations, GRI Bio is strategically positioned to emerge as a leader in the expanding microbiome therapeutics sector. Its commitment to improving patient outcomes underscores its potential to make substantial contributions to the evolution of healthcare solutions.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-10.93M |
| Operating Margin | 0.00% |
| Return on Equity | -185.70% |
| Return on Assets | -88.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.65 |
| Price-to-Book | 0.35 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.77M |
| Float | $1.77M |
| % Insiders | 0.46% |
| % Institutions | 1.59% |
Historical Volatility
HV 10-Day
63.14%
HV 20-Day
56.09%
HV 30-Day
54.64%
HV 60-Day
71.43%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($25.00 target)
2
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026